Carolyn T Bramante Selected Research

Carolyn T Bramante Research Topics

21	COVID-19 05/2024 - 06/2020
11	Obesity 01/2024 - 01/2019
7	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2021
4	Post-Acute COVID-19 Syndrome 05/2024 - 12/2022
4	Weight Loss (Weight Reduction) 11/2023 - 01/2019
3	Infections 11/2022 - 01/2022
2	Morbid Obesity 01/2024 - 09/2019
2	Overweight 10/2023 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 09/2020
2	Pediatric Obesity 09/2019 - 01/2019
1	Weight Gain 11/2023
1	Hypertension (High Blood Pressure) 11/2023
1	Disease Progression 11/2023
1	Body Weight (Weight, Body) 01/2023
1	Cough 01/2023
1	Diarrhea 01/2023
1	Fatigue 01/2023
1	Fever (Fevers) 01/2023
1	Headache (Headaches) 01/2023
1	Hyperglycemia 01/2023
1	Nausea 01/2023
1	Prediabetic State (Prediabetes) 01/2023
1	Chills 01/2023
1	Myalgia 01/2023
1	Venous Thromboembolism 10/2022
1	Pneumonia (Pneumonitis) 10/2022
1	Non-alcoholic Fatty Liver Disease 10/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Human Influenza (Influenza) 01/2021
1	Hepatitis C 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Retinal Detachment (Retinal Detachments) 11/2011
1	Retinal Perforations 11/2011

16	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 06/2020
8	Fluvoxamine (Luvox)FDA LinkGeneric 11/2023 - 01/2022
8	Ivermectin (Mectizan)FDA Link 10/2023 - 01/2022
2	Antiviral Agents (Antivirals)IBA 05/2024 - 06/2023
2	Hemoglobins (Hemoglobin)IBA 11/2023 - 01/2021
2	Liraglutide FDA Link 01/2023 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 06/2020
1	Phentermine (Adipex-P)FDA LinkGeneric 01/2024
1	Topiramate (Topamax)FDA LinkGeneric 01/2024
1	Mirtazapine (Rexer)FDA LinkGeneric 11/2023
1	Glyburide (Glibenclamide)FDA LinkGeneric 11/2023
1	Glucose (Dextrose)FDA LinkGeneric 11/2023
1	Antidepressive Agents (Antidepressants)IBA 11/2023
1	Amitriptyline (Elavil)FDA LinkGeneric 11/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023
1	tirzepatideIBA 11/2023
1	Peptides (Polypeptides)IBA 11/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2023
1	Insulin (Novolin)FDA Link 11/2023
1	AntigensIBA 10/2023
1	vasectrin I (VS I)IBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	VaccinesIBA 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021
1	MTOR InhibitorsIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	A-factor (Streptomyces)IBA 01/2019
1	Retinaldehyde (Retinal)IBA 11/2011

6	Therapeutics 01/2024 - 01/2019
4	Bariatric Surgery 11/2023 - 01/2019
4	Drug Therapy (Chemotherapy) 11/2023 - 01/2019
2	Artificial Respiration (Mechanical Ventilation) 11/2022 - 01/2021
1	Gastrectomy 11/2023
1	Gastroplasty (Vertical-Banded Gastroplasty) 11/2023
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2023
1	Ambulatory Care (Outpatient Care) 11/2023
1	Glycemic Control 11/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Length of Stay 01/2022
1	Precision Medicine 01/2019
1	Scleral Buckling 11/2011
1	Vitrectomy 11/2011